Keyword Search Subscribe to receive breaking news alerts about uniQure. Subscribe Year None202420232022202120202019201820172016 Date Title Aug 01, 2024 uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update Jul 23, 2024 uniQure Announces Closing of Sale of Manufacturing Facility to Genezen Jul 09, 2024 uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease Jul 01, 2024 uniQure Announces Sale of Commercial Manufacturing Facility to Genezen Jun 03, 2024 uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease May 07, 2024 uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »